Evidence map›Paper›PMID 27432980›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing.

Franklin T Moutos, Katherine A Glass, Sarah A Compton, Alison K Ross, Charles A Gersbach, Farshid Guilak, Bradley T Estes

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Teaming up to overcome challenges toward translation of new therapeutics for osteoarthritis.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Functional tissue engineering of articular cartilage for biological joint resurfacing-The 2021 Elizabeth Winston Lanier Kappa Delta Award.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Franklin T MoutosCytex Therapeutics, Durham, NC 27705;
Katherine A GlassDepartment of Orthopedic Surgery, Washington University, St. Louis, MO 63110; Shriners Hospitals for Children, St. Louis, MO 63110; Department of Biomedical Engineering, Duke University, Durham, NC 27708.
Sarah A ComptonCytex Therapeutics, Durham, NC 27705;
Alison K RossDepartment of Orthopedic Surgery, Washington University, St. Louis, MO 63110; Shriners Hospitals for Children, St. Louis, MO 63110;
Charles A GersbachDepartment of Biomedical Engineering, Duke University, Durham, NC 27708.
Farshid GuilakCytex Therapeutics, Durham, NC 27705; Department of Orthopedic Surgery, Washington University, St. Louis, MO 63110; Shriners Hospitals for Children, St. Louis, MO 63110; Department of Biomedical Engineering, Duke University, Durham, NC 27708 guilakf@wudosis.wustl.edu bradley.estes@cytextherapeutics.com.ORCID 0000-0001-7380-0330
Bradley T EstesCytex Therapeutics, Durham, NC 27705; guilakf@wudosis.wustl.edu bradley.estes@cytextherapeutics.com.
Cytex Therapeutics (United States) · USDuke University · USWashington University in St. Louis · US

Funding

Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI SILVA, MATTHEW J · 2009 to 2018
$5.7M
OBESITY, BIOMECHANICS, AND INFLAMMATION IN OSTEOARTHRITISR01AG046927 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2013 to 2023
$3.2M
Mechanical and Osmotic Signaling in ChondrocytesR01AR048182 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2013
$3.0M
Intrinsic Repair of the Knee MeniscusR01AR048852 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2007 to 2011
$1.4M
Functional Tissue Engineering for Cartilage RepairR42AR055042 · NIAMS · CYTEX THERAPEUTICS INC. · PI GUILAK, FARSHID · 2013 to 2014
$1.3M
Scaffold-Mediated Gene Delivery for Engineering of Osteochondral TissuesR21AR067467 · NIAMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A., GUILAK, FARSHID · 2015 to 2016
$366k
Functional Tissue Engineering for Cartilage RepairR41AR055042 · NIAMS · CYTEX THERAPEUTICS INC. · PI GUILAK, FARSHID · 2009 to 2009
$262k
NIAMS NIH HHS P01 AR050245NIAMS NIH HHS P30 AR057235NIAMS NIH HHS R01 AR048182NIAMS NIH HHS R01 AR048852NIAMS NIH HHS R21 AR067467NIAMS NIH HHS R41 AR055042NIAMS NIH HHS R42 AR055042NIA NIH HHS R01 AG015768NIA NIH HHS R01 AG046927
6 · The paper itself

Abstract

Biological resurfacing of entire articular surfaces represents an important but challenging strategy for treatment of cartilage degeneration that occurs in osteoarthritis. Not only does this approach require anatomically sized and functional engineered cartilage, but the inflammatory environment within an arthritic joint may also inhibit chondrogenesis and induce degradation of native and engineered cartilage. The goal of this study was to use adult stem cells to engineer anatomically shaped, functional cartilage constructs capable of tunable and inducible expression of antiinflammatory molecules, specifically IL-1 receptor antagonist (IL-1Ra). Large (22-mm-diameter) hemispherical scaffolds were fabricated from 3D woven poly(ε-caprolactone) (PCL) fibers into two different configurations and seeded with human adipose-derived stem cells (ASCs). Doxycycline (dox)-inducible lentiviral vectors containing eGFP or IL-1Ra transgenes were immobilized to the PCL to transduce ASCs upon seeding, and constructs were cultured in chondrogenic conditions for 28 d. Constructs showed biomimetic cartilage properties and uniform tissue growth while maintaining their anatomic shape throughout culture. IL-1Ra-expressing constructs produced nearly 1 µg/mL of IL-1Ra upon controlled induction with dox. Treatment with IL-1 significantly increased matrix metalloprotease activity in the conditioned media of eGFP-expressing constructs but not in IL-1Ra-expressing constructs. Our findings show that advanced textile manufacturing combined with scaffold-mediated gene delivery can be used to tissue engineer large anatomically shaped cartilage constructs that possess controlled delivery of anticytokine therapy. Importantly, these cartilage constructs have the potential to provide mechanical functionality immediately upon implantation, as they will need to replace a majority, if not the entire joint surface to restore function.

Indexed as

Adipose TissueAdultAdult Stem CellsCartilage, ArticularCells, CulturedChondrocytesChondrogenesisFemaleHumansInterleukin 1 Receptor Antagonist ProteinMiddle AgedOsteoarthritisReproducibility of ResultsTissue EngineeringTissue ScaffoldsInterleukin 1 Receptor Antagonist Proteincartilage repairgene therapymesenchymal stem cellosteoarthritistissue engineering

Identifiers

PMID27432980
PMCPMC4978289
OpenAlexW2505322038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.